Legal Opinion

Gen-Probe Incorporated, Plaintiff-Cross v. Vysis, Inc.

Court of Appeals for the Federal Circuit

Decided March 5, 2004No. 02-1617, 02-1618PublishedCited by 55 opinions

1Opinion of the Court

RADER, Circuit Judge.

After a jury trial, the United States District Court for the Southern District California entered judgment in favor of the declaratory judgment plaintiff, Gen-Probe. Among other rulings, the district court found that substantial evidence supported the jury’s verdicts of noninfringement and invalidity for both obviousness and nonen-ablement. Gen- Probe, Inc. v. Vysis, Inc., No. 99-CV-2668 H(AJB) (S.D.Cal. Aug. 2, 2002). Vysis has appealed issues relating to subject matter jurisdiction, claim construction, noninfringement, obviousness, and nonenablement. Gen-Probe…

2Cases cited22 opinions

  1. Aetna Life Insurance v. HaworthSupreme Court of the United States · 1937
  2. Maryland Casualty Co. v. Pacific Coal & Oil Co.Supreme Court of the United States · 1941
  3. American Fire & Casualty Co. v. FinnSupreme Court of the United States · 1951
  4. A.C. Aukerman Company v. R.L. Chaides Construction Co.Court of Appeals for the Federal Circuit · 1992
  5. Lear, Inc. v. AdkinsSupreme Court of the United States · 1969

17 more not listed; retrieve them via the Exa API.

3Cited by55 opinions

  1. MedImmune, Inc. v. Genentech, Inc.Supreme Court of the United States · 2007
  2. Metabolite Laboratories, Inc. And Competitive Technologies, Inc. v. Laboratory Corporation of America Holdings (Doing Business as Labcorp)Court of Appeals for the Federal Circuit · 2004
  3. Nike, Inc. v. ALREADY, LLCCourt of Appeals for the Second Circuit · 2011
  4. SanDisk Corp. v. STMicroelectronics, Inc.Court of Appeals for the Federal Circuit · 2007
  5. Teva Pharmaceuticals Usa, Inc. v. Novartis Pharmaceuticals Corporation, Novartis Pharma Ag and Novartis International Pharmaceutical Ltd.Court of Appeals for the Federal Circuit · 2007

50 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API